%D8%AA%D9%84%D9%8A%D9%81_%D8%B1%D8%A6%D9%88%D9%8AFibrosis_pulmonarFibrosi_pulmonarCategory:Pulmonary_fibrosisPlicn%C3%AD_fibr%C3%B3zaFfibrosis_yr_ysgyfaintLungenfibrosePulmonary_fibrosisFibrosis_pulmonar%D9%81%DB%8C%D8%A8%D8%B1%D9%88%D8%B2_%D8%B1%DB%8C%D9%87KeuhkofibroosiFibrose_pulmonaireFibrose_pulmonarFibrosis_paruFibrosi_polmonare%ED%8F%90%EC%84%AC%EC%9C%A0%EC%A6%9D%D0%9F%D0%BD%D0%B5%D0%B2%D0%BC%D0%BE%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7Fibrosis_pulmonumFibrosis_paru-paruLongfibroseLungefibroseFibrose_pulmonarPulmonary_fibrosisLungfibros%D0%9F%D0%BD%D0%B5%D0%B2%D0%BC%D0%BE%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%9F%D0%BD%D0%B5%D0%B2%D0%BC%D0%BE%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7X%C6%A1_ph%E1%BB%95iQ32446
about
Lung fibrosisDemetris ChristofiasRole of Genetic Factors in the Development of Lung DiseaseSafety, Tolerability, and Efficacy Study of Idiopathic Pulmonary FibrosisMapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung SpecimensStudy to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy AdultsStudy of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudySafety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) PatientsRace, Ethnicity, and Diffuse Parenchymal Lung DiseaseStudy of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseGenomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesCorrelating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)Pulmonary Fibrosis and Telomerase Mutation StudyIPF Drug Deposition StudyViral Pathogenesis of Early Cystic Fibrosis Lung DiseaseAutoantibody Reduction Therapy in Patients With Idiopathic Pulmonary FibrosisThe Occurence of Inflammation and Oxidative Stress in Lung DiseasesThe Influence of Personality on Pulmonary Fibrosis and SarcoidosisTo Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy VolunteersNutritional Assessment in Idiopathic Pulmonary FibrosisBPF Genetics of ILD StudySelf-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary FibrosisPFOX: Pulmonary Fibrosis Ambulatory Oxygen TrialInhaled NAC in Treatment of IPFTraditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and MetabolomicsA Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical TreatmentEvolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving PirfenidoneAcute Effects of Oxygen Supplementation Among IPF PatientsFamilies-At-risk for Interstitial Lung Disease StudyInhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisEZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionStudy of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseProcurement and Analysis of Specimens From Individuals With Pulmonary FibrosisLung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular CharacterizationTargeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary FibrosisEffects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis
P1050
P1855
Marcus BorgLiam ClancyDinaAhmed FagihElwyn Ralph BerlekampMary Jane RussellJoseph A. UnanueArthur J. England, Jr.Mario Santos, Jr.Jacques Rougeau, Sr.Mark ShepherdPeter StonePeter ArundellGeorge BandyMarco Aurelio DenegriMatt LambNicholas Gilman ThacherNorman ZabuskyJuan Martín Moreira ViteriRoland MarchandJohn Michael HayesSteve GerberAl SwiftDaryl DukeHarold LeavittGerry JolyJohn ConnallyJohnny WilsonMarcel MaréchalMickey NewburyDavid Manker AbshireArchbishop Iakovos of AmericaCarlo Federico GrossoTerrel BellAnthony HicksBarbara B. SmithBobby ClancyDanny NewmanDavid EvansDennis Linde
P509
P828
Autophagy in idiopathic pulmonary fibrosisA micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosisThe effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationNitrofurantoin-induced pulmonary fibrosis: a case reportIdiopathic pulmonary fibrosis."Nonspecific" interstitial pulmonary fibrosis: association with asbestos fibers detected by electron microscopyDeterminants of progression in idiopathic pulmonary fibrosisDeterminants of survival in idiopathic pulmonary fibrosisExposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workersOccupational risks for idiopathic pulmonary fibrosis mortality in the United StatesApplication of laser scanning confocal microscopy in the analysis of particle-induced pulmonary fibrosisInteractive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosisInduction of pulmonary fibrosis by cerium oxide nanoparticlesCommon and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agentsRelative release of interleukin-1beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosisLung fibrosis in plutonium workers.Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in ratsQuantitative image analysis of drug-induced lung fibrosis using laser scanning confocal microscopyDeterminants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosisEnhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposureCis-4-[18F] fluoro-L-proline PET imaging of pulmonary fibrosis in a rabbit modelPET imaging of pulmonary fibrosis - replyGlucocorticoid with cyclophosphamide for paraquat-induced lung fibrosisGlucocorticoid with cyclophosphamide for paraquat-induced lung fibrosisGlucocorticoid with cyclophosphamide for paraquat-induced lung fibrosisNon-steroid agents for idiopathic pulmonary fibrosisGlucocorticoid with cyclophosphamide for paraquat-induced lung fibrosisCorticosteroids for idiopathic pulmonary fibrosisImmunomodulatory agents for idiopathic pulmonary fibrosisBone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosisExpression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytesRegulation of pulmonary fibrosis by chemokine receptor CXCR3Inhibition and role of let-7d in idiopathic pulmonary fibrosisCombined pulmonary fibrosis and emphysema syndrome: a reviewRegulation of transforming growth factor-β1-driven lung fibrosis by galectin-3The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important differenceChronic idiopathic pulmonary fibrosis in a West Highland white terrierThe significance of nanoparticles in particle-induced pulmonary fibrosisGene expression profiles of acute exacerbations of idiopathic pulmonary fibrosisWNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
P921
description
Krankheitsbild in der Pneumologie
@de
enfermedad pulmonar interstici ...... pulmonar por tejido conectivo
@es
human disease
@en
irreversibel och restriktiv lungsjukdom
@sv
malattia dell'apparato respiratorio
@it
nifer o wahanol gyflyrau sy’n achosi i feinwe greithiol hel yn yr ysgyfaint
@cy
plicní choroba
@cs
sairaus
@fi
sykdom i åndedrettssystemet
@nb
чалавечае захворваньне
@be-tarask
name
Ffibrosis yr ysgyfaint
@cy
Fibrose pulmonar
@gl
Fibrosis paru-paru
@ms
Fibrosis pulmonar
@ast
Fibrosis pulmonum
@la
Lungenfibrose
@de
Plicní fibróza
@cs
Xơ phổi
@vi
fibrose pulmonaire
@fr
fibrose pulmonar
@pt
type
label
Ffibrosis yr ysgyfaint
@cy
Fibrose pulmonar
@gl
Fibrosis paru-paru
@ms
Fibrosis pulmonar
@ast
Fibrosis pulmonum
@la
Lungenfibrose
@de
Plicní fibróza
@cs
Xơ phổi
@vi
fibrose pulmonaire
@fr
fibrose pulmonar
@pt
altLabel
Fibrose intersticielle
@fr
Fibrosis of lung (disorder)
@en
Fibrosis of lung
@en
Fibrosis of the lung
@en
Pneumopatia cronica interstiziale
@it
fibróza plic
@cs
interstitial fibrosis
@en
lung fibrosis
@en
pulmonal fibrose
@nn
лёгачны фіброз
@be-tarask
prefLabel
Ffibrosis yr ysgyfaint
@cy
Fibrose pulmonar
@gl
Fibrosis paru-paru
@ms
Fibrosis pulmonar
@ast
Fibrosis pulmonum
@la
Lungenfibrose
@de
Plicní fibróza
@cs
Xơ phổi
@vi
fibrose pulmonaire
@fr
fibrose pulmonar
@pt
P2347
P244
P486
P508
P672
P1296
P1417
science/pulmonary-fibrosis
P1461
pulmonary-fibrosis
P1748
P1995
P2347
P244
sh85109004
P2892
P3417
Pulmonary-Fibrosis
P373
Pulmonary fibrosis
P3827
pulmonary-fibrosis
P3841
HP:0002206